نتایج جستجو برای: prostacyclin

تعداد نتایج: 3701  

Journal: :European Journal of Vascular and Endovascular Surgery 1996

Journal: :Circulation 2001
S K Shyue M J Tsai J Y Liou J T Willerson K K Wu

BACKGROUND We tested the hypothesis that combined cyclooxygenase-1 (COX-1) and prostacyclin synthase (PGIS) gene transfer selectively augments prostacyclin production without a concurrent overproduction of other prostanoids. METHODS AND RESULTS ECV304 cells were transfected with bicistronic pCOX-1/PGIS versus pCOX-1 or pPGIS, and prostanoids were analyzed. Contrary to the high prostaglandin E...

2013
May-Jywan Tsai Ching-Feng Weng Nien-Chu Yu Dann-Ying Liou Fu-San Kuo Ming-Chao Huang Wen-Cheng Huang Kabik Tam Song-Kun Shyue Henrich Cheng

Prostacyclin (PGI2), a potent vasodilator and platelet antiaggregatory eicosanoid, is cytoprotective in cerebral circulation. It is synthesized from arachidonic acid (AA) by the sequential action of cyclooxygenase- (COX-) 1 or 2 and prostacyclin synthase (PGIS). Because prostacyclin is unstable in vivo, PGI2 analogs have been developed and demonstrated to protect against brain ischemia. This wo...

Journal: :Circulation research 1981
N F Voelkel J G Gerber I F McMurtry A S Nies J T Reeves

Prostaglandins are generated by the lungs and released into the circulation. Since inhibitors of prostaglandin synthesis enhance hypoxic pulmonary vasoconstriction, we wondered whether vasodilator prostacyclin was synthesized by the lungs in response to vasoconstriction. To test this hypothesis, we measured vasoconstriction induced by angiotensin II in isolated rat lungs before and after inhibi...

Journal: :British medical journal 1982
S P Hanley J Bevan S R Cockbill S Heptinstall

The effects of different regimens of 40 mg aspirin on platelet thromboxane A2 synthesis and vascular prostacyclin synthesis were determined in patients who were undergoing elective surgery for removal of varicose veins. Aspirin 40 mg taken at intervals of 48 hours consistently reduced platelet thromboxane A2 synthesis to a level at which it failed to support platelet aggregation and the associa...

2005
BRENDAN J. R. WHITTLE

SINCE THE TIME of the discovery of prostacyclin' and the elucidation of its chemical structure as prostaglandin (PG) (5Z)-9 deoxy-6, 9 a-epoxy-&APGF,,2 many synthetic prostacyclin analogues have been prepared and reported in the literature. Although prostacyclin (epoprostenol) is now available for clinical use as the freeze-dried sodium salt that, when mixed with the diluent buffer (sodium chlo...

Journal: :Stroke 1983
R J Gryglewski S Nowak E Kostka-Trabka J Kusmiderski A Dembinska-Kiec K Bieron M Basista B Blaszczyk

Ten patients with ischaemic stroke were treated with prostacyclin (2.5-5.0 ng/kg/min i.v. in 6 h courses 4-10 times during 1-2.5 days). In all patients a dramatic regression of hemiplegia, or hemiparesis, or aphasia occurred in the first few hours of prostacyclin infusion. Four to eight weeks later 6 patients left the clinic without neurological deficit; 3 patients had minor residual hemiparesi...

Journal: :Arteriosclerosis 1988
J A Jakubowski R Vaillancourt D Deykin

Ethanol partitions into cellular membranes and alters membrane-associated phenomena in numerous cell types. Since platelet aggregation and its inhibition by prostacyclin are mediated by membrane-associated receptors and enzymes, we examined the interaction of ethanol, prostacyclin, and aspirin on human platelet reactivity. Using platelet-rich plasma, we examined the effect of increasing concent...

Journal: :Human reproduction 2005
C Hermenegildo P J Oviedo M C García-Martínez M A García-Pérez J J Tarín A Cano

BACKGROUND The effects of progestogens on endothelial physiology are poorly studied. Prostacyclin is a potent vasodilator synthesized by two isoforms of cyclooxygenase (COX) in endothelium. We examined the effects of two clinically used progestogens, progesterone and medroxyprogesterone acetate (MPA), on prostacyclin production by cultured human umbilical vein endothelial cells (HUVEC) and the ...

Journal: :European respiratory review : an official journal of the European Respiratory Society 2015
Irene M Lang Sean P Gaine

Pulmonary arterial hypertension (PAH) is a severe disease characterised by increased pulmonary vascular resistance, which leads to restricted pulmonary arterial blood flow and elevated pulmonary arterial pressure. In patients with PAH, pulmonary concentrations of prostacyclin, a prostanoid that targets several receptors including the IP prostacyclin receptor, are reduced. To redress this balanc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید